A monoclonal antibody-dextran-Sn(IV) chlorin e6 immunoconjugate was prepared by a technique involving the site-specific covalent modification of the monoclonal antibody oligosaccharide moiety. Dextran carriers were synthesized with a single chain-terminal hydrazide group, which was used as the coupling point between the carrier and the monoclonal antibody carbohydrate. Selective in vitro photolysis of SK-MEL-2 human malignant melanoma cells was accomplished using several conjugates prepared from anti-melanoma 2.1 (chromophore:antibody molar ratios, 6.8 and 11.2). 
icity, as measured by clonogenic assay, was dependent on the delivered dose of 634-nm light and was observed only for conjugates that bound SK-MEL-2 cells. As judged by competitive inhibition radioimmunoassay, conjugates prepared in this fashion showed excellent retention of antigen binding activity relative to the unmodified antibody.
Over the past decade, advances in monoclonal antibody (mAb) technology (1) have provided the opportunity to study the potential of mAbs to selectively deliver a variety of active agents (e.g., drugs, toxins, radioisotopes) to cell surfaces (2) (3) (4) (5) (6) (7) (8) . The selectivity of such conjugates can be compromised by shared antigen cross-reactivity or by nonspecific uptake of the conjugates (9, 10) . By employing photosensitizer (PS) active agents, these potential drawbacks are minimized as a result of the double selectivity required (i.e., antigen binding coupled with light activation of the PS). Although extensive work with PS alone has been reported (11, 12) , comparatively few studies on mAb'PS immunoconjugates have been published (13, 14) .
Reports on the use of mAb-PS conjugates have highlighted the need for a general method for producing active, chemically defined immunoconjugates. Most direct coupling procedures have modified amino acid side chains (13, 15) and produced structurally heterogenous populations of immunoconjugates with a range of binding properties (16) . Efforts to direct the PS to a particular site on the mAb (e.g., carbohydrate) have produced more homogenous conjugates but appear limited in the number of PSs that can be coupled to a single mAb. An additional feature of previous conjugation schemes is that a significant fraction of the PS is physically adsorbed and not covalently bound to the mAb.
The present report documents the development of a reproducible technique for the assembly of chemically defined active immunoconjugates containing the PS Sn(IV) chlorin e6 (SnCe6). In the present technique, multiple PSs are covalently linked to the mAb through an end-functionalized dextran carrier. The carrier polymer method allows for preparation of reproducible mAb-PS conjugates with a range of PS-mAb molar ratios and generalization to other active agents (e.g., drugs, toxins, radioisotopes). Anti-melanomaSnCe6 immunoconjugates prepared in this fashion were shown to be immunologically active and effective in selectively killing SK-MEL-2 human malignant melanoma cells.
MATERIALS AND METHODS
Synthesis of SnCe6-Dextran Carrier. The synthetic schemes used in the current work are outlined in Fig. 1 (17) . Dextran (Pharmacia T-40; weight average molecular weight =35,000) was chosen as the carrier polymer because it is water soluble, is nontoxic, and possesses a single reducing terminus. A reactive hydrazide group was added to the reducing terminus via reductive amination with a large excess of apidic dihydrazide in the presence of sodium cyanoborohydride (18, 19) . Titration of the reducing end in I using the dinitrosalicylate method (20) showed a 92% modification of the terminal aldehyde relative to unaltered dextran. To prevent modification of the chain-terminal hydrazide in I prior to linkage to the antibody, a Trt protection group was introduced via the active ester TCPPH to yield II. In addition to providing a protected terminal hydrazide, the TCPPH was also designed to introduce a six-carbon spacer group on the dextran terminus in order to facilitate subsequent linkage to the mAb. The presence of the terminal Trt protection group was verified by visible spectroscopy ofthe Trt cation (Amax = 430 nm) following digestion of II with 60% HCl04 (21) .
The terminally protected trityl-hydrazidodextran (II) was allowed to react with ethyl chloroformate in dimethyl sulfoxide DMSO containing triethylamine to yield the dextrantrans-carbonate (22) . The isolated dextran-trans-carbonate was subjected to solvolysis with hydrazine hydrate to produce the dextran carbazate (HI). SnCe6, prepared using the general method of Falk (23) (IV) HOi NINpH5. Preparation of Injunocogojugates. Conjugates were prepared by oxidation of the mAb oligosaccharide moiety with 20 mM NaIO4 in 0.15 M acetate buffer (pH 4.75) for 15 min at room temperature (25) , followed by addition of ethylene glycol to scavenge excess periodate. The oxidized mAb was passed over a PD-10 (Pharmacia) column equilibrated with acetate buffer to remove low molecular weight by-products and incubated with a 50-fold molar excess of V in acetate buffer at 40C for 48 hr with the exclusion of light. The conjugates were purified by a two-step procedure using protein G (Pharmacia) affinity chromatography (24) to remove unbound V, followed by chromatography on a Sephacryl S-300 column equilibrated with Dulbecco's phosphatebuffered saline (DPBS) to remove unconjugated mAb. (28) . RESULTS
The spectrum of all conjugates examined (Fig. 2) showed broadening of the Soret and red absorption bands with the the conjugated and unconjugated mAbs; however, all of the heavy chain from the purified conjugates migrated to a region ofhigher molecular weight (""120,000-140,000) than that seen for unmodified heavy chain (50,000-55,000) (17) . Prior to silver staining, the modified heavy chain band was noticeably colored green, indicating comigration of the dye with the modified heavy chain. Since the conjugation chemistry employed would result in a heavy chain protein component of molecular weight 50,000 to which a dextran carrier is coupled (average molecular weight 35 (Fig. 3) . Cells were plated from grepared. Table 1 logarithmic phase cultures at low density to allow irradiation and assay in the same well. A characteristic sublethal region was noted for light doses of <10 J/cm2 for each conjugate examined. Conjugates completely killed the target melanoma cells at an incident radiation dose of 50 J/cm2. An identical light dose caused less than a 15% decrease in surviving cell fraction following incubation with a nonbinding conjugate prepared from anti-lymphoma 2.130. Photolysis of the target cells as a function of energy appeared to depend on the SnCe6:mAb molar ratio. The conjugate with the highest ratio (ratio = 11.2) was able to kill half of the cells at a light dose of 8 J/cm2, whereas an identical level of target cell photolysis required almost 15 J/cm2 for a conjugate with fewer SnCe6 molecules per mAb (ratio = 6.8).
DISCUSSION
In the present report, SnCe6 was used as the active PS in the selective photolysis of malignant melanoma cells. Several properties of SnCe6 render it a potentially attractive candidate for photodynamic cell killing. First, SnCe6 shows significant long-wavelength absorbance (634 nm), which permits its use in biological systems containing endogenous chromophores that absorb below 600 nm. Second, the apparent quantum efficiency of singlet oxygen generation ((A) for SnCe6 has been shown to be 2-fold greater than that of the metal-free chlorin e6 under conditions of matched absorbance at the principal red band for each PS (data not shown). Recent studies of metallo-and metal-free chlorin e6 derivatives have shown that the efficiency of singlet molecular oxygen (1Ad) generation and the chromophore photostability are governed by the identity of the central metal atom (29 As a consequence of non-site-specifc linkage methods, reduced activity of the active agent and the mAb has been reported (2, 31, 32) . Recently, coupling techniques have been developed that exploit the Fc oligosaccharide residues in mAbs (33) . Such methods allow coupling of active agent to the mAb at a point distal to the antigen binding sites, with substantial retention of mAb binding activity and active agent efficacy. However, due to the limited number of oligosaccharide residues available for attachment, the ratio of active agent to mAb using these direct methods is frequently low.
For example, using direct attachment of radionuclide chelators to the carbohydrate of mAbs, Rodwell et al. (16) reported chelator:mAb ratios of 5. To increase the ratio of active agent covalently coupled to mAb, polymeric carriers have been used as bridges between the active agent and the mAb (14, 34, 35 (Fig. 3) showed a sublethal damage region below 10 J/cm2 followed by logarithmic cell killing to nearly complete cell death at higher light doses. The existence of a sublethal damage region for photodynamic cell killing has been established previously for a variety of cells and PS (26, 36 or mAb conjugates. Moreover, the spectral changes that occurred when the chromophore was found (Fig. 1) suggest that at least a portion of the bound chromophore may have undergone some substantive changes. These changes might include structural modifications that may have occurred during the immunoconjugate synthesis and/or chromophore aggregation that may occur when chromophores are immobilized on a random coiling macromolecule like dextran. Further characterization of these immunoconjugates is necessary using structural techniques and time-resolved spectroscopy to directly measure the IAg for each conjugate as compared to the free SnCe6. The technique of immunoconjugate preparation described in this report can be used in a wide variety of applications. Because the dextran-PS conjugates are assembled prior to mAb conjugation, a variety of suitably derivatized active agents including other PSs, drugs, and radioisotope chelators can be used without the need for complete modification ofthe method for each particular agent. Though a practical limit of about 10-15 SnCe6 molecules per dextran chain was obtained using the techniques described in the present work, other less bulky active agents displaying greater aqueous solubility may allow for higher degrees of active agent coupling.
